Abstract
We prospectively evaluated the performance of Cepheid's GeneXpert Xpert Flu assay in a target population of 281 adults presenting to the emergency department with an acute respiratory illness who met Centers for Disease Control and Prevention (CDC) criteria for recommended antiviral treatment. Compared with the Prodesse ProFlu+ assay, Xpert Flu had an overall sensitivity of 95.3% and specificity of 99.2%.
Original language | English (US) |
---|---|
Pages (from-to) | 4353-4355 |
Number of pages | 3 |
Journal | Journal of clinical microbiology |
Volume | 52 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2014 |
ASJC Scopus subject areas
- Microbiology (medical)